Navigation Links
Future diabetes treatment may use resveratrol to target the brain
Date:10/6/2009

Chevy Chase, MDResveratrol, a molecule found in red grapes, has been shown to improve diabetes when delivered orally to rodents. Until now, however, little has been known about how these beneficial changes are mediated in the body. A new study accepted for publication in Endocrinology, a journal of The Endocrine Society, shows that the brain plays a key role in mediating resveratrol's anti-diabetic actions, potentially paving the way for future orally-delivered diabetes medications that target the brain.

Resveratrol activates sirtuins, a class of proteins that are thought to underlie many of the beneficial effects of calorie restriction. Previous studies in mice have provided compelling evidence that when sirtuins are activated by resveratrol, diabetes is improved. Sirtuin activators are now being tested in humans as anti-diabetic compounds.

Sirtuins are expressed virtually everywhere throughout the body and until now, little has been known about what tissues mediate resveratrol's beneficial effects. Knowing where in the body the beneficial effects of activated sirtuins are mediated could help in the development of more effective targeted diabetes medications.

"We know that sirtuins are expressed in parts of the brain known to govern glucose metabolism, so we hypothesized that the brain could be mediating resveratrol's anti-diabetic actions," said Roberto Coppari, PhD, of the University of Texas Southwestern Medical Center and co-author of the study. "To test the hypothesis, we assessed the metabolic consequences of delivering resveratrol directly into the brain of diabetic mice. We found that resveratrol did activate sirtuins in the brain of these mice which resulted in improving their high levels of blood sugar and insulin."

"These findings may lead to new strategies in the fight against type 2 diabetes," said Coppari. "By knowing that the brain mediates resveratrol's anti-diabetic actions, industry can now focus on developing sirtuin activators that directly target the brain. When orally-delivered, these drugs will likely improve diabetes without affecting the other organs in which activation of sirtuins may not always be beneficial."


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Terumo Heart, Inc.'s DuraHeart™ Left-Ventricular Assist System Featured at Future of Health Technology Summit
2. Where surgery was the standard, casting may be the future
3. Obese Middle-Aged Women Face Unhealthy Future
4. Country United symposium explores collaborative future of military medicine
5. Norm Augustine to keynote symposium on accelerators for Americas future
6. Call for Proposals for Partners Investing in Nursings Future
7. Kidney Injury While Hospitalized May Lead to Future Dialysis
8. Future of Autos, Future of Health Care to Be Examined by the Michigan State Medical Society and the Michigan Dental Association
9. The future of schizophrenia
10. Harold Hank Gardner M.D. Named in the Future Health 100
11. Lord Stevens Commission Publishes Roadmap to Ensure Future of Equestrian Sport
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 2017 , ... First Choice Emergency Room , the ... anniversary of its Houston-Fallbrook facility. , “We are honored to celebrate the ... First Choice Emergency Room Houston-Fallbrook. “It has been a pleasure serving the north ...
(Date:9/22/2017)... ... September 22, 2017 , ... The ... at customers’ doorstep. According to Smart Mart, customers can now order vegetable, fruit, ... wearable, and customers can find clothing at discounted prices. Apart from this, Smart ...
(Date:9/21/2017)... VA (PRWEB) , ... September 21, 2017 , ... ... Webinar**, Sept. 26, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices ... It’s easy to get things wrong, run afoul of The Quality System Regulation ...
(Date:9/21/2017)... ... 2017 , ... Demonstrating a consistent and continued commitment to ... awarded five-year accreditation status through the Public Health Accreditation Board (PHAB). ... a PHAB-accredited health department now extend to more than 203 million people, or ...
(Date:9/21/2017)... ... 2017 , ... Preora Diagnostics Inc. , a privately ... received two prestigious recognitions that acknowledge the promise of its PWS Nanoctyology platform ... been named a Top 100 Finalist for the 16th annual Chicago Innovation Awards ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
(Date:9/9/2017)... Sept. 8, 2017 Dealmed Medical Supplies, ... of medical equipment, supplies, drugs, vaccines, and specialty medical ... into an agreement to acquire Vantage Medical Supplies, a ... Holtsville, New York . ... new and emerging medical practices, will operate under the ...
Breaking Medicine Technology: